Co-Diagnostics Inc (NASDAQ: CODX) is in a rebound after a steep drop in the last two weeks. Today, the company has announced receipt of FDA authorization for its COVID-19 test. The company announced that its Logix Smart ™ COVID-19 test had got EUA (Emergency Use Authorization) by...
Genprex Inc. (NASDAQ: GNPX) maintained upside momentum in yesterday’s session, and closed the day with gains of 23.44%. This came after news that, independent researchers had found the company’s TUSC2 to be a possible novel biomarker for treating thyroid cancer. The results found that, the overexpression of...
Altimmune Inc (NASDAQ: ALT) was one of the top gainers in Friday’s session. The stock rallied to close with gains of 110.23%. This came after the company announced completing the design and synthesis of a vaccine for preventing COVID-19. The company said that it was now taking...
Cemtrex Inc (NASDAQ: CETX) opened yesterday’s session with a gap up, and closed the day with gains of 54.24%. This happened after the company made a press release announcing that, it had received an order of more than $700k for advanced equipment.  The order was from municipal...
China Online Education Group (NYSE: COE) was one of the top gainers at the close of the week, and has been gaining upside momentum for the better part of the month. Some days back, the company reported some impressive Q3 results that showed significant growth in revenues.
Protagonist Therapeutics Inc (NASDAQ: PTGX) was one of the top gainers in Wednesday’s trading session. The stock rallied to close the day with gains of 72.92%. This came a day after it announced early results for its ongoing phase 2 study for PTG-300. The preliminary results were...
Technical Communications Corporation (NASDAQ: TCCO) was one of the top gainers in Tuesday’s trading session. The stock gained by 308.16% to close the day at $8.00. This followed the company’s return to profitability after losses in the last financial year. On the 9th...
Genprex Inc (NASDAQ:GNPX) was a top gainer in yesterday’s trading session. The stock rallied to close the day with gains of 29.84%, after announcing an exclusive licensing deal with the University of Pittsburgh for a therapy that could potentially cure Type 1 and 2 diabetes.
Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) was one of the top gainers in yesterday’s trading session. The stock rallied by 50% to close the day at $3.60. This followed a positive rating by 10 rating firms. Seven of them had a consensus of, “buy” rating for this stock,...
Trillium Therapeutics Inc (NASDAQ: TRIL) was a big gainer in yesterday’s trading session, and closed the day with gains of 93.96%. This came after the company announced progress on its TTI-621 and TTI-622 clinical programs. The CEO, Jan Skvarka announced that, the company...